Pub Date : 2024-12-20DOI: 10.1016/j.bjao.2024.100364
Ankita Miglani , Sandeep Miglani , Hassan M. Tawfik , Thomas Drew
Background
Emergency Front of Neck access (eFONA) via cricothyroidotomy using a size 6 internal diameter tracheal tube is recommended by the Difficult Airway Society in the event of a ‘can't intubate, can't oxygenate’ (CICO) scenario in adults. There is a lack of clear guidance on whether to retain or remove a previously inserted supraglottic airway device (SAD) before eFONA. We aimed to study the effect of both neck extension and insertion of an SAD on sagittal cricothyroid membrane (CTM) height.
Methods
We recruited 40 adult female patients attending for minor gynaecological surgery under general anaesthesia and suitable for an SAD. Sagittal ultrasound images of the CTM were obtained in the neutral and extended neck position, both before and after insertion of the i-gel® (160 images). The CTM height was measured from the images by a blinded assessor and the data analysed to determine the magnitude of change in CTM height and its relevance for cricothyroidotomy.
Results
There was a significant difference in the height of the CTM between the groups (P<0.001). The extended neck position accounted for 10% increase over the neutral position. Inserting an i-gel® and extending the neck increased the CTM height by 26% over neutral position, thereby lengthening it sufficiently to accommodate a size 6.0 tracheal tube in 100% of the patients.
Conclusions
Both neck extension and the insertion of an i-gel® increased the sagittal height of the CTM. This suggests there may be benefit to retaining or re-inserting an SAD during eFONA.
{"title":"Both the extended neck position and insertion of a supraglottic airway device increases the height of the cricothyroid membrane in females. A prospective observational study","authors":"Ankita Miglani , Sandeep Miglani , Hassan M. Tawfik , Thomas Drew","doi":"10.1016/j.bjao.2024.100364","DOIUrl":"10.1016/j.bjao.2024.100364","url":null,"abstract":"<div><h3>Background</h3><div>Emergency Front of Neck access <strong>(</strong>eFONA) via cricothyroidotomy using a size 6 internal diameter tracheal tube is recommended by the Difficult Airway Society in the event of a ‘can't intubate, can't oxygenate’ (CICO) scenario in adults. There is a lack of clear guidance on whether to retain or remove a previously inserted supraglottic airway device (SAD) before eFONA. We aimed to study the effect of both neck extension and insertion of an SAD on sagittal cricothyroid membrane (CTM) height.</div></div><div><h3>Methods</h3><div>We recruited 40 adult female patients attending for minor gynaecological surgery under general anaesthesia and suitable for an SAD. Sagittal ultrasound images of the CTM were obtained in the neutral and extended neck position, both before and after insertion of the i-gel® (160 images). The CTM height was measured from the images by a blinded assessor and the data analysed to determine the magnitude of change in CTM height and its relevance for cricothyroidotomy.</div></div><div><h3>Results</h3><div>There was a significant difference in the height of the CTM between the groups (<em>P</em><0.001). The extended neck position accounted for 10% increase over the neutral position. Inserting an i-gel® and extending the neck increased the CTM height by 26% over neutral position, thereby lengthening it sufficiently to accommodate a size 6.0 tracheal tube in 100% of the patients.</div></div><div><h3>Conclusions</h3><div>Both neck extension and the insertion of an i-gel® increased the sagittal height of the CTM. This suggests there may be benefit to retaining or re-inserting an SAD during eFONA.</div></div>","PeriodicalId":72418,"journal":{"name":"BJA open","volume":"13 ","pages":"Article 100364"},"PeriodicalIF":0.0,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11729672/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142985542","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-16DOI: 10.1016/j.bjao.2024.100359
Kaitlin Kramer , Thomas Payne , Mitchell Brooks , Jessica Barry , Neha Mahajan , Samantha Malcolm , Hannah Braithwaite , Alex Wang , Chris Thompson , Keith Liyanagama , Robert D. Sanders
Background
Intraoperative awareness, without explicit recall, occurs after induction of anaesthesia in approximately 10% of persons under 40 yr of age. Most anaesthetic agents minimally suppress the noradrenergic system. We hypothesised that addition of dexmedetomidine, which suppresses noradrenergic activity, may reduce encephalographic (EEG) arousal in response to tracheal intubation; such an effect would lay the foundation for future studies of dexmedetomidine in reducing intraoperative awareness.
Methods
A single-site randomised, placebo-controlled trial with sex-based stratification was conducted. Participants, aged 18–40 yr old, undergoing intubation for general anaesthesia were eligible for recruitment and randomly allocated to receive dexmedetomidine or placebo. Dexmedetomidine (0.5 μg kg−1) was given as a 5-min loading dose before induction. Bispectral index (BIS) values were collected during the induction phase of anaesthesia and the isolated forearm technique was used to assess patients' responsiveness before and after tracheal intubation. The primary outcome was the effect of dexmedetomidine on changes in BIS from pre-to postintubation.
Results
A total of 51 patients were recruited and included in the primary analysis. We did not observe an effect of dexmedetomidine on changes in BIS after tracheal intubation (mean difference –1.13, 95% confidence interval [CI] –4.87 to 2.62; p=0.556). Dexmedetomidine reduced the estimated plasma propofol concentration at loss of responsiveness (difference [dexmedetomidine – placebo]: –1.06 μg ml−1, 95% CI –1.66 to –0.46; p<0.001) and before intubation (difference [dexmedetomidine – placebo]: –1.84 μg ml−1, 95% CI –2.79 to –0.90; p<0.001). There was one patient in the placebo group who gave positive responses in the isolated forearm test before and after tracheal intubation.
Conclusions
Dexmedetomidine demonstrated an anaesthetic-sparing effect at induction of anaesthesia but did not prevent EEG arousal after tracheal intubation, as defined by an increase in the BIS value.
Clinical Trial Registration
Australia and New Zealand Clinical Trials Registry (Trial ID: ACTRN12622000754741).
背景:在 40 岁以下的人群中,约有 10% 的人在麻醉诱导后会出现术中意识,但没有明确的回忆。大多数麻醉剂对去甲肾上腺素能系统的抑制作用微乎其微。我们假设,加入右美托咪定可抑制去甲肾上腺素能活性,从而降低气管插管时的脑电图(EEG)唤醒;这种效果将为今后研究右美托咪定降低术中意识奠定基础:方法:进行了一项基于性别分层的单点随机安慰剂对照试验。年龄在18-40岁之间、接受插管全身麻醉的参与者均符合招募条件,并被随机分配接受右美托咪定或安慰剂。右美托咪定(0.5 μg kg-1)在诱导前 5 分钟以负荷剂量给药。在麻醉诱导阶段收集双谱指数(BIS)值,并在气管插管前后使用孤立前臂技术评估患者的反应性。主要结果是右美托咪定对插管前到插管后 BIS 变化的影响:共招募了 51 名患者并纳入主要分析。我们没有观察到右美托咪定对气管插管后 BIS 变化的影响(平均差-1.13,95% 置信区间 [CI] -4.87 至 2.62;P=0.556)。右美托咪定降低了失去响应时的估计血浆异丙酚浓度(差异[右美托咪定-安慰剂]:-1.06 μg ml-1,95% CI -1.66 至 -0.46;p-1,95% CI -2.79 至 -0.90;p结论:右美托咪定在麻醉诱导时显示出了节省麻醉剂的效果,但并不能防止气管插管后的脑电图唤醒,脑电图唤醒的定义是BIS值的增加:临床试验注册:澳大利亚和新西兰临床试验注册中心(试验编号:ACTRN12622000754741)。
{"title":"Noradrenergic suppression to reduce electroencephalographic arousal after intubation: a randomised, placebo-controlled trial","authors":"Kaitlin Kramer , Thomas Payne , Mitchell Brooks , Jessica Barry , Neha Mahajan , Samantha Malcolm , Hannah Braithwaite , Alex Wang , Chris Thompson , Keith Liyanagama , Robert D. Sanders","doi":"10.1016/j.bjao.2024.100359","DOIUrl":"10.1016/j.bjao.2024.100359","url":null,"abstract":"<div><h3>Background</h3><div>Intraoperative awareness, without explicit recall, occurs after induction of anaesthesia in approximately 10% of persons under 40 yr of age. Most anaesthetic agents minimally suppress the noradrenergic system. We hypothesised that addition of dexmedetomidine, which suppresses noradrenergic activity, may reduce encephalographic (EEG) arousal in response to tracheal intubation; such an effect would lay the foundation for future studies of dexmedetomidine in reducing intraoperative awareness.</div></div><div><h3>Methods</h3><div>A single-site randomised, placebo-controlled trial with sex-based stratification was conducted. Participants, aged 18–40 yr old, undergoing intubation for general anaesthesia were eligible for recruitment and randomly allocated to receive dexmedetomidine or placebo. Dexmedetomidine (0.5 μg kg<sup>−1</sup>) was given as a 5-min loading dose before induction. Bispectral index (BIS) values were collected during the induction phase of anaesthesia and the isolated forearm technique was used to assess patients' responsiveness before and after tracheal intubation. The primary outcome was the effect of dexmedetomidine on changes in BIS from pre-to postintubation.</div></div><div><h3>Results</h3><div>A total of 51 patients were recruited and included in the primary analysis. We did not observe an effect of dexmedetomidine on changes in BIS after tracheal intubation (mean difference –1.13, 95% confidence interval [CI] –4.87 to 2.62; <em>p</em>=0.556). Dexmedetomidine reduced the estimated plasma propofol concentration at loss of responsiveness (difference [dexmedetomidine – placebo]: –1.06 μg ml<sup>−1</sup>, 95% CI –1.66 to –0.46; <em>p</em><0.001) and before intubation (difference [dexmedetomidine – placebo]: –1.84 μg ml<sup>−1</sup>, 95% CI –2.79 to –0.90; <em>p</em><0.001). There was one patient in the placebo group who gave positive responses in the isolated forearm test before and after tracheal intubation.</div></div><div><h3>Conclusions</h3><div>Dexmedetomidine demonstrated an anaesthetic-sparing effect at induction of anaesthesia but did not prevent EEG arousal after tracheal intubation, as defined by an increase in the BIS value.</div></div><div><h3>Clinical Trial Registration</h3><div>Australia and New Zealand Clinical Trials Registry (Trial ID: ACTRN12622000754741).</div></div>","PeriodicalId":72418,"journal":{"name":"BJA open","volume":"13 ","pages":"Article 100359"},"PeriodicalIF":0.0,"publicationDate":"2024-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11711814/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142973655","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-16DOI: 10.1016/j.bjao.2024.100360
Jennifer R. Wang, Eric Oh, Benjamin Aronow, Wendy K. Bernstein
Requests for medical and anaesthetic care that is ‘vegan’ or free of animal-derived components are becoming increasingly common in the cultural landscape. Such requests are often rooted in religious beliefs and practices. There are currently no requirements for the disclosure of animal-derived components in medical items. However, both patients and medical professionals agree that greater transparency regarding such items is needed in obtaining informed consent. Although the ethical argument for disclosure has been established, there remain gaps in practical guidelines in recognising animal-derived components in medical items and understanding how to avoid them. This lack of comprehensive knowledge leads to challenges in initiating conversations about appropriate medication selection.
This manuscript will outline the common dietary restrictions of various religious groups and provide instruction on common animal-derived ingredients in medications. It will also introduce potential viable animal-free alternatives for some commonly used medications in the perioperative environment which has not been done previously in the literature. Moreover, we note the broader implications and reasoning behind considering dietary restrictions in medication choices.
{"title":"The unseen animal behind medicine: exploring considerations of animal-derived medications and anaesthetics in today's landscape","authors":"Jennifer R. Wang, Eric Oh, Benjamin Aronow, Wendy K. Bernstein","doi":"10.1016/j.bjao.2024.100360","DOIUrl":"10.1016/j.bjao.2024.100360","url":null,"abstract":"<div><div>Requests for medical and anaesthetic care that is ‘vegan’ or free of animal-derived components are becoming increasingly common in the cultural landscape. Such requests are often rooted in religious beliefs and practices. There are currently no requirements for the disclosure of animal-derived components in medical items. However, both patients and medical professionals agree that greater transparency regarding such items is needed in obtaining informed consent. Although the ethical argument for disclosure has been established, there remain gaps in practical guidelines in recognising animal-derived components in medical items and understanding how to avoid them. This lack of comprehensive knowledge leads to challenges in initiating conversations about appropriate medication selection.</div><div>This manuscript will outline the common dietary restrictions of various religious groups and provide instruction on common animal-derived ingredients in medications. It will also introduce potential viable animal-free alternatives for some commonly used medications in the perioperative environment which has not been done previously in the literature. Moreover, we note the broader implications and reasoning behind considering dietary restrictions in medication choices.</div></div>","PeriodicalId":72418,"journal":{"name":"BJA open","volume":"13 ","pages":"Article 100360"},"PeriodicalIF":0.0,"publicationDate":"2024-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11719331/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142973658","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-01DOI: 10.1016/j.bjao.2024.100358
Steven McGuigan , Andria Pelentritou , David A. Scott , Jamie Sleigh
Background
Administration of conventional anaesthetic agents is associated with changes in electroencephalogram (EEG) oscillatory dynamics, including a reduction in the peak alpha frequency. Computational models of neurones can reproduce such phenomena and are valuable tools for investigating their underlying mechanisms. We hypothesised that EEG data acquired during xenon anaesthesia in humans would show similar changes in peak alpha frequency and that computational neuronal models of recognised cellular actions of xenon would be consistent with the observed changes.
Methods
EEG recordings were obtained for 11 participants from a randomised controlled trial of xenon anaesthesia and for 21 participants from a volunteer study of xenon administration. The frontal peak alpha frequency was calculated for both cohorts at awake baseline and during xenon administration. In silico simulations with two computational models of neurones were performed to investigate how xenon antagonism of hyperpolarisation-activated cyclic nucleotide-gated channel 2 (HCN2) and glutamatergic excitatory neurotransmission would influence peak alpha frequency.
Results
Compared with awake baseline, frontal peak alpha frequency was significantly lower during xenon administration in the randomised controlled trial cohort, median (inter-quartile range) frequency 7.73 Hz (7.27–8.08 Hz) vs 8.81 Hz (8.35–9.03 Hz), P=0.012, and the volunteer cohort, 8.69 Hz (8.34–8.98 Hz) vs 9.41 Hz (9.11–9.92 Hz), P=0.001. In silico simulations with both computational models suggest that antagonism of HCN2 and glutamatergic excitatory neurotransmission are associated with a reduction in peak alpha frequency.
Conclusions
Xenon administration is associated with a reduction of peak alpha frequency in the frontal EEG. In silico simulations utilising two computational models of neurones suggest that these changes are consistent with antagonism of HCN2 and glutamatergic excitatory neurotransmission.
Clinical trial registration
The Australian New Zealand Clinical Trials Registry: ANZCTR number 12618000916246.
背景:常规麻醉药的施用与脑电图振荡动力学的变化有关,包括α峰频率的降低。神经元的计算模型可以再现这种现象,并且是研究其潜在机制的宝贵工具。我们假设人类在氙气麻醉期间获得的脑电图数据将显示出类似的α峰频率变化,并且识别氙气细胞作用的计算神经元模型将与观察到的变化一致。方法收集11例氙气麻醉随机对照试验和21例氙气给药志愿者的脑电图记录。计算两组受试者在清醒基线和氙气治疗期间的额叶α峰频率。利用两种神经元计算模型进行了计算机模拟,研究了超极化激活的环核苷酸门控通道2 (HCN2)和谷氨酸能兴奋性神经传递的氙拮抗作用如何影响α峰频率。结果与清醒基线相比,随机对照试验队列中(四分位数范围)中位频率7.73 Hz (7.27-8.08 Hz) vs 8.81 Hz (8.35-9.03 Hz)显著降低,志愿者队列中(四分位数范围)中位频率为8.69 Hz (8.34-8.98 Hz) vs 9.41 Hz (9.11-9.92 Hz), P=0.012。两种计算模型的计算机模拟表明,HCN2和谷氨酸能兴奋性神经传递的拮抗作用与α峰频率的降低有关。结论氙气处理与额叶脑电图α峰频率降低有关。利用两种神经元计算模型的计算机模拟表明,这些变化与HCN2和谷氨酸能兴奋性神经传递的拮抗作用是一致的。临床试验注册澳大利亚新西兰临床试验注册中心:ANZCTR编号12618000916246。
{"title":"Xenon anaesthesia is associated with a reduction in frontal electroencephalogram peak alpha frequency","authors":"Steven McGuigan , Andria Pelentritou , David A. Scott , Jamie Sleigh","doi":"10.1016/j.bjao.2024.100358","DOIUrl":"10.1016/j.bjao.2024.100358","url":null,"abstract":"<div><h3>Background</h3><div>Administration of conventional anaesthetic agents is associated with changes in electroencephalogram (EEG) oscillatory dynamics, including a reduction in the peak alpha frequency. Computational models of neurones can reproduce such phenomena and are valuable tools for investigating their underlying mechanisms. We hypothesised that EEG data acquired during xenon anaesthesia in humans would show similar changes in peak alpha frequency and that computational neuronal models of recognised cellular actions of xenon would be consistent with the observed changes.</div></div><div><h3>Methods</h3><div>EEG recordings were obtained for 11 participants from a randomised controlled trial of xenon anaesthesia and for 21 participants from a volunteer study of xenon administration. The frontal peak alpha frequency was calculated for both cohorts at awake baseline and during xenon administration. <em>In silico</em> simulations with two computational models of neurones were performed to investigate how xenon antagonism of hyperpolarisation-activated cyclic nucleotide-gated channel 2 (HCN2) and glutamatergic excitatory neurotransmission would influence peak alpha frequency.</div></div><div><h3>Results</h3><div>Compared with awake baseline, frontal peak alpha frequency was significantly lower during xenon administration in the randomised controlled trial cohort, median (inter-quartile range) frequency 7.73 Hz (7.27–8.08 Hz) <em>vs</em> 8.81 Hz (8.35–9.03 Hz), <em>P</em>=0.012, and the volunteer cohort, 8.69 Hz (8.34–8.98 Hz) <em>vs</em> 9.41 Hz (9.11–9.92 Hz), <em>P</em>=0.001. <em>In silico</em> simulations with both computational models suggest that antagonism of HCN2 and glutamatergic excitatory neurotransmission are associated with a reduction in peak alpha frequency.</div></div><div><h3>Conclusions</h3><div>Xenon administration is associated with a reduction of peak alpha frequency in the frontal EEG. <em>In silico</em> simulations utilising two computational models of neurones suggest that these changes are consistent with antagonism of HCN2 and glutamatergic excitatory neurotransmission.</div></div><div><h3>Clinical trial registration</h3><div>The Australian New Zealand Clinical Trials Registry: ANZCTR number 12618000916246.</div></div>","PeriodicalId":72418,"journal":{"name":"BJA open","volume":"12 ","pages":"Article 100358"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142757540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-01DOI: 10.1016/j.bjao.2024.100361
Andy Yuet Meng Ng, Thomas Emery
{"title":"Moderate or severe pain in recovery after major elective surgery: A pilot retrospective analysis to identify those at risk","authors":"Andy Yuet Meng Ng, Thomas Emery","doi":"10.1016/j.bjao.2024.100361","DOIUrl":"10.1016/j.bjao.2024.100361","url":null,"abstract":"","PeriodicalId":72418,"journal":{"name":"BJA open","volume":"12 ","pages":"Article 100361"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142759047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Acute kidney injury (AKI) is a common complication among patients requiring cardiopulmonary bypass (CPB) during paediatric cardiac surgery. Plasma-free haemoglobin (PFH) produced by haemolysis during CPB contributes to AKI. This study aimed to determine the association between PFH and postoperative AKI during paediatric cardiac surgery requiring CPB.
Methods
This prospective, single-centre, observational study included children aged <5 yr who underwent cardiac surgery requiring CPB. PFH was measured pre-CPB, every 30 min during CPB, after modified ultrafiltration, on ICU admission, and once a day at 1–3 days after surgery. The study outcome included the relationship between peak PFH concentrations and the development of postoperative AKI up to 3 days after surgery. Additionally, multivariable analysis was performed to determine the risk factors for AKI.
Results
Of 179 patients, 74 (41%) developed postoperative AKI. Patients who developed AKI had significantly higher peak PFH concentrations (80 mg dl−1 [inter-quartile range, 50–132.5] vs 60 mg dl−1 [40–100]; P=0.006). Multivariable analysis did not identify peak PFH concentrations as an independent risk factor for postoperative AKI (odds ratio [OR] 1.00; 95% confidence interval [CI]: 0.99–1.00; P=0.268). Factors associated with postoperative AKI were age in months (OR 0.96; 95% CI: 0.94–0.99; P=0.007) and CPB duration (OR 1.02; 95% CI: 1.01–1.02; P<0.001).
Conclusions
There was an association between postoperative AKI and CPB time rather than PFH. Perioperative peak PFH concentrations were significantly higher in patients with postoperative AKI after paediatric cardiac surgery requiring CPB.
背景急性肾损伤(AKI)是儿科心脏手术中需要进行心肺旁路术(CPB)的患者常见的并发症。CPB 期间溶血产生的无血浆血红蛋白(PFH)是导致 AKI 的原因之一。本研究旨在确定需要进行 CPB 的儿科心脏手术中 PFH 与术后 AKI 之间的关系。方法这项前瞻性、单中心、观察性研究纳入了接受需要进行 CPB 的心脏手术的 5 岁儿童。在 CPB 前、CPB 期间每 30 分钟、改良超滤后、ICU 入院时以及术后 1-3 天每天测量一次 PFH。研究结果包括 PFH 峰值浓度与术后 3 天内发生术后 AKI 的关系。结果 在179名患者中,74人(41%)发生了术后AKI。发生 AKI 的患者的 PFH 峰值浓度明显更高(80 毫克/升 [四分位间范围,50-132.5] vs 60 毫克/升 [40-100];P=0.006)。多变量分析并未发现峰值 PFH 浓度是术后 AKI 的独立风险因素(几率比 [OR] 1.00;95% 置信区间 [CI]:0.99-1.00;P=0.268)。与术后 AKI 相关的因素是以月为单位的年龄(OR 0.96;95% CI:0.94-0.99;P=0.007)和 CPB 持续时间(OR 1.02;95% CI:1.01-1.02;P<0.001)。需要 CPB 的儿科心脏手术后出现术后 AKI 的患者围术期 PFH 峰值浓度明显更高。
{"title":"Association between plasma-free haemoglobin and postoperative acute kidney injury in paediatric cardiac surgery: a prospective observational study","authors":"Takanobu Sakura, Tomoyuki Kanazawa, Tatsuhiko Shimizu, Kazuyoshi Shimizu, Tatsuo Iwasaki, Hiroshi Morimatsu","doi":"10.1016/j.bjao.2024.100348","DOIUrl":"10.1016/j.bjao.2024.100348","url":null,"abstract":"<div><h3>Background</h3><div>Acute kidney injury (AKI) is a common complication among patients requiring cardiopulmonary bypass (CPB) during paediatric cardiac surgery. Plasma-free haemoglobin (PFH) produced by haemolysis during CPB contributes to AKI. This study aimed to determine the association between PFH and postoperative AKI during paediatric cardiac surgery requiring CPB.</div></div><div><h3>Methods</h3><div>This prospective, single-centre, observational study included children aged <5 yr who underwent cardiac surgery requiring CPB. PFH was measured pre-CPB, every 30 min during CPB, after modified ultrafiltration, on ICU admission, and once a day at 1–3 days after surgery. The study outcome included the relationship between peak PFH concentrations and the development of postoperative AKI up to 3 days after surgery. Additionally, multivariable analysis was performed to determine the risk factors for AKI.</div></div><div><h3>Results</h3><div>Of 179 patients, 74 (41%) developed postoperative AKI. Patients who developed AKI had significantly higher peak PFH concentrations (80 mg dl<sup>−1</sup> [inter-quartile range, 50–132.5] <em>vs</em> 60 mg dl<sup>−1</sup> [40–100]; <em>P</em>=0.006). Multivariable analysis did not identify peak PFH concentrations as an independent risk factor for postoperative AKI (odds ratio [OR] 1.00; 95% confidence interval [CI]: 0.99–1.00; <em>P</em>=0.268). Factors associated with postoperative AKI were age in months (OR 0.96; 95% CI: 0.94–0.99; <em>P</em>=0.007) and CPB duration (OR 1.02; 95% CI: 1.01–1.02; <em>P</em><0.001).</div></div><div><h3>Conclusions</h3><div>There was an association between postoperative AKI and CPB time rather than PFH. Perioperative peak PFH concentrations were significantly higher in patients with postoperative AKI after paediatric cardiac surgery requiring CPB.</div></div>","PeriodicalId":72418,"journal":{"name":"BJA open","volume":"12 ","pages":"Article 100348"},"PeriodicalIF":0.0,"publicationDate":"2024-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142528395","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-17DOI: 10.1016/j.bjao.2024.100346
Alexandre Garioud, Michael Seltz Kristensen
When performing tracheal intubation guided by a flexible optical scope, the operator may lose the anatomical orientation and hypoxia may occur. Oxygen insufflation through the working channel of the flexible optical scope is used by anaesthetists to prevent blurring of the lens and to prevent hypoxia. However, fatal iatrogenic injuries from this method are reported. Our aim is to review the current literature on oxygen insufflation through the working channel during tracheal intubation guided by a flexible optical scope, to identify its benefits and the source of its dangers, and ultimately to provide a basis for the development of a safer technique. We conducted a literature search of databases, guidelines, and textbooks using search terms related to oxygen insufflation through the working channel during intubation guided by a flexible optical scope. Clinical trials confirm that the technique results in better visibility and better oxygenation during intubation. Gastric rupture and pneumothorax were the most frequent types of injury. We identified that oxygen insufflation without pressure limitation during accidental misplacement of the flexible optical scope in the oesophagus, deep in the lower airways, or via a tear of the airway mucosa was the cause of barotrauma. We conclude that a delivered pressure below 40 cm H2O will likely carry a low risk of serious adverse outcomes. The technique in its current form seems unsafe, and future research should aim at developing a system that delivers oxygen at pressures respecting gastric and airway physiologic pressure thresholds with a flow sufficient to obtain the documented advantages of the technique.
{"title":"Oxygen insufflation via the working channel during tracheal intubation guided by a flexible optical scope and benefits, dangers, and future of the method: a narrative review","authors":"Alexandre Garioud, Michael Seltz Kristensen","doi":"10.1016/j.bjao.2024.100346","DOIUrl":"10.1016/j.bjao.2024.100346","url":null,"abstract":"<div><div>When performing tracheal intubation guided by a flexible optical scope, the operator may lose the anatomical orientation and hypoxia may occur. Oxygen insufflation through the working channel of the flexible optical scope is used by anaesthetists to prevent blurring of the lens and to prevent hypoxia. However, fatal iatrogenic injuries from this method are reported. Our aim is to review the current literature on oxygen insufflation through the working channel during tracheal intubation guided by a flexible optical scope, to identify its benefits and the source of its dangers, and ultimately to provide a basis for the development of a safer technique. We conducted a literature search of databases, guidelines, and textbooks using search terms related to oxygen insufflation through the working channel during intubation guided by a flexible optical scope. Clinical trials confirm that the technique results in better visibility and better oxygenation during intubation. Gastric rupture and pneumothorax were the most frequent types of injury. We identified that oxygen insufflation without pressure limitation during accidental misplacement of the flexible optical scope in the oesophagus, deep in the lower airways, or via a tear of the airway mucosa was the cause of barotrauma. We conclude that a delivered pressure below 40 cm H<sub>2</sub>O will likely carry a low risk of serious adverse outcomes. The technique in its current form seems unsafe, and future research should aim at developing a system that delivers oxygen at pressures respecting gastric and airway physiologic pressure thresholds with a flow sufficient to obtain the documented advantages of the technique.</div></div>","PeriodicalId":72418,"journal":{"name":"BJA open","volume":"12 ","pages":"Article 100346"},"PeriodicalIF":0.0,"publicationDate":"2024-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142444855","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-14DOI: 10.1016/j.bjao.2024.100345
Jakob Zeuchner , Louise Elander , Jessica Frisk , Michelle S. Chew
Background
Postoperative acute kidney injury is a common occurrence among patients undergoing major abdominal surgery and is associated with adverse outcomes. The effect of an incremental increase in serum creatinine concentration not meeting the KDIGO criteria for acute kidney injury is poorly studied. We evaluated the incidence and trajectories of postoperative subclinical acute kidney injury (sPO-AKI), acute kidney injury (PO-AKI), acute kidney disease (PO-AKD), and their relationships with chronic kidney disease (CKD), major adverse kidney events (MAKE30), and all-cause mortality at 30 days after surgery.
Methods
In a pre-planned, nested cohort sub study of the Myocardial Injury in Noncardiac Surgery in Sweden (MINSS) study, we included 588 patients from two hospitals. We determined the incidence of PO-AKI, PO-AKD, and CKD according to the ADQI-POQI consensus criteria. sPO-AKI was defined as a 25–49% increase in serum creatinine concentration within 7 days of surgery.
Results
A total of 59 (10.2%) patients fulfilled the criteria for sPO-AKI, 41 (7.1%) patients for PO-AKI, 29 (6.2%) for PO-AKD, and 6 (1.2%) for CKD. Similar proportions of patients with sPO-AKI and PO-AKI developed PO-AKD. An association was identified between the combined group of sPO-AKI and PO-AKI and 30-day mortality (Cramer's V: 0.1, P=0.037). PO-AKD (Cramer's V: 0.4, P<0.001) was associated with MAKE30 and 30-day mortality. All patients with CKD had pre-existing PO-AKD.
Conclusions
Subclinical postoperative kidney injury not fulfilling the KDIGO criteria occurred in every 10th patient, and one in 14 suffered from PO-AKI after major abdominal surgery. A majority of PO-AKD cases was preceded by sPO-AKI and PO-AKI. Early kidney injuries were associated with longer-term adverse outcomes including MAKE30, 30-day mortality, and CKD.
{"title":"Incidence and trajectories of subclinical and KDIGO-defined postoperative acute kidney injury in patients undergoing major abdominal surgery","authors":"Jakob Zeuchner , Louise Elander , Jessica Frisk , Michelle S. Chew","doi":"10.1016/j.bjao.2024.100345","DOIUrl":"10.1016/j.bjao.2024.100345","url":null,"abstract":"<div><h3>Background</h3><div>Postoperative acute kidney injury is a common occurrence among patients undergoing major abdominal surgery and is associated with adverse outcomes. The effect of an incremental increase in serum creatinine concentration not meeting the KDIGO criteria for acute kidney injury is poorly studied. We evaluated the incidence and trajectories of postoperative subclinical acute kidney injury (sPO-AKI), acute kidney injury (PO-AKI), acute kidney disease (PO-AKD), and their relationships with chronic kidney disease (CKD), major adverse kidney events (MAKE30), and all-cause mortality at 30 days after surgery.</div></div><div><h3>Methods</h3><div>In a pre-planned, nested cohort sub study of the Myocardial Injury in Noncardiac Surgery in Sweden (MINSS) study, we included 588 patients from two hospitals. We determined the incidence of PO-AKI, PO-AKD, and CKD according to the ADQI-POQI consensus criteria. sPO-AKI was defined as a 25–49% increase in serum creatinine concentration within 7 days of surgery.</div></div><div><h3>Results</h3><div>A total of 59 (10.2%) patients fulfilled the criteria for sPO-AKI, 41 (7.1%) patients for PO-AKI, 29 (6.2%) for PO-AKD, and 6 (1.2%) for CKD. Similar proportions of patients with sPO-AKI and PO-AKI developed PO-AKD. An association was identified between the combined group of sPO-AKI and PO-AKI and 30-day mortality (Cramer's V: 0.1, <em>P</em>=0.037). PO-AKD (Cramer's V: 0.4, <em>P</em><0.001) was associated with MAKE30 and 30-day mortality. All patients with CKD had pre-existing PO-AKD.</div></div><div><h3>Conclusions</h3><div>Subclinical postoperative kidney injury not fulfilling the KDIGO criteria occurred in every 10th patient, and one in 14 suffered from PO-AKI after major abdominal surgery. A majority of PO-AKD cases was preceded by sPO-AKI and PO-AKI. Early kidney injuries were associated with longer-term adverse outcomes including MAKE30, 30-day mortality, and CKD.</div></div>","PeriodicalId":72418,"journal":{"name":"BJA open","volume":"12 ","pages":"Article 100345"},"PeriodicalIF":0.0,"publicationDate":"2024-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142432087","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-12DOI: 10.1016/j.bjao.2024.100347
Lichy Han , David A. Purger , Sarah L. Eagleman , Casey H. Halpern , Vivek Buch , Samantha M. Gaston , Babak Razavi , Kimford Meador , David R. Drover
Background
Maintaining an appropriate depth of anaesthesia is important for avoiding adverse effects from undermedication or overmedication during surgery. Electroencephalography (EEG) has become increasingly used to achieve this balance. Investigating the predictive power of intracranial EEG (iEEG) and scalp EEG for different levels of sedation could increase the utility of EEG monitoring.
Methods
Simultaneous iEEG, scalp EEG, and Observer's Assessment of Alertness/Sedation (OAA/S) scores were recorded during emergence from anaesthesia in seven patients undergoing placement of intracranial electrodes for medically refractory epilepsy. A deep learning model was constructed to predict an OAA/S score of 0–2 vs 3–5 using iEEG, scalp EEG, and their combination. An additional five patients with only scalp EEG data were used for independent validation. Models were evaluated using the area under the receiver-operating characteristic curve (AUC).
Results
Combining scalp EEG and iEEG yielded significantly better prediction (AUC=0.795, P<0.001) compared with iEEG only (AUC=0.750, P=0.02) or scalp EEG only (AUC=0.764, P<0.001). The validation scalp EEG only data resulted in an AUC of 0.844. Combining the two modalities appeared to capture spatiotemporal advantages from both modalities.
Conclusions
The combination of iEEG and scalp EEG better predicted sedation level than either modality alone. The scalp EEG only model achieved a similar AUC to the combined model and maintained its performance in additional patients, suggesting that scalp EEG models are likely sufficient for real-time monitoring. Deep learning approaches using multiple leads to capture a wider area of brain activity may help augment existing EEG monitors for prediction of sedation.
{"title":"Deep learning models using intracranial and scalp EEG for predicting sedation level during emergence from anaesthesia","authors":"Lichy Han , David A. Purger , Sarah L. Eagleman , Casey H. Halpern , Vivek Buch , Samantha M. Gaston , Babak Razavi , Kimford Meador , David R. Drover","doi":"10.1016/j.bjao.2024.100347","DOIUrl":"10.1016/j.bjao.2024.100347","url":null,"abstract":"<div><h3>Background</h3><div>Maintaining an appropriate depth of anaesthesia is important for avoiding adverse effects from undermedication or overmedication during surgery. Electroencephalography (EEG) has become increasingly used to achieve this balance. Investigating the predictive power of intracranial EEG (iEEG) and scalp EEG for different levels of sedation could increase the utility of EEG monitoring.</div></div><div><h3>Methods</h3><div>Simultaneous iEEG, scalp EEG, and Observer's Assessment of Alertness/Sedation (OAA/S) scores were recorded during emergence from anaesthesia in seven patients undergoing placement of intracranial electrodes for medically refractory epilepsy. A deep learning model was constructed to predict an OAA/S score of 0–2 <em>vs</em> 3–5 using iEEG, scalp EEG, and their combination. An additional five patients with only scalp EEG data were used for independent validation. Models were evaluated using the area under the receiver-operating characteristic curve (AUC).</div></div><div><h3>Results</h3><div>Combining scalp EEG and iEEG yielded significantly better prediction (AUC=0.795, <em>P</em><0.001) compared with iEEG only (AUC=0.750, <em>P</em>=0.02) or scalp EEG only (AUC=0.764, <em>P</em><0.001). The validation scalp EEG only data resulted in an AUC of 0.844. Combining the two modalities appeared to capture spatiotemporal advantages from both modalities.</div></div><div><h3>Conclusions</h3><div>The combination of iEEG and scalp EEG better predicted sedation level than either modality alone. The scalp EEG only model achieved a similar AUC to the combined model and maintained its performance in additional patients, suggesting that scalp EEG models are likely sufficient for real-time monitoring. Deep learning approaches using multiple leads to capture a wider area of brain activity may help augment existing EEG monitors for prediction of sedation.</div></div>","PeriodicalId":72418,"journal":{"name":"BJA open","volume":"12 ","pages":"Article 100347"},"PeriodicalIF":0.0,"publicationDate":"2024-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142417278","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-05DOI: 10.1016/j.bjao.2024.100349
Thomas Payne , Jennifer Taylor , David Kunkel , Katherine Konieczka , Frankie Ingram , Kaj Blennow , Henrik Zetterberg , Robert A. Pearce , Anke Meyer-Franke , Niccolò Terrando , Katerina Akassoglou , Robert D. Sanders , Richard C. Lennertz
Background
We aimed to assess perioperative changes in fibrinogen in the cerebrospinal fluid (CSF), their association with markers of blood–brain barrier breakdown and neuroinflammation, and their association with postoperative delirium severity.
Methods
We conducted a secondary analysis of the Interventions for Postoperative Delirium-Biomarker 2 (IPOD-B2, NCT02926417) study, a prospective observational cohort study. We included 24 patients aged >21 yr undergoing aortic aneurysm repair. CSF samples were obtained before (n=24) and after surgery (n=13), with some participants having multiple postoperative samples. Our primary outcome was the perioperative change in CSF fibrinogen. Delirium was assessed using the Delirium Rating Scale-Revised-98.
Results
CSF fibrinogen increased after surgery (P<0.001), and this was associated with an increase in CSF/plasma albumin ratio (β=1.09, 95% CI 0.47–1.71, P=0.004). The peak change in CSF fibrinogen was associated with the change in CSF interleukin (IL)-10 and IL-12p70. The peak change in CSF fibrinogen was associated with the change in CSF total tau (β=0.47, 95% CI 0.24–0.71, P=0.002); however, we did not observe an association with postoperative delirium severity (incidence rate ratio = 1.20, 95% CI 0.66–2.17, P=0.540).
Conclusions
Our preliminary findings support the hypothesis that fibrinogen enters the brain via blood-brain barrier disruption, promoting neuroinflammation and neuronal injury. However, we did not observe an association between cerebrospinal fluid fibrinogen and peak delirium severity in this limited cohort.
背景我们旨在评估围手术期脑脊液(CSF)中纤维蛋白原的变化、它们与血脑屏障破坏和神经炎症标志物的关联以及它们与术后谵妄严重程度的关联。方法我们对一项前瞻性观察性队列研究--术后谵妄干预-生物标志物 2(IPOD-B2,NCT02926417)研究进行了二次分析。我们纳入了 24 名年龄为 21 岁、接受主动脉瘤修补术的患者。我们在手术前(24 人)和手术后(13 人)采集了 CSF 样本,其中一些参与者在术后采集了多个样本。我们的主要结果是围手术期 CSF 纤维蛋白原的变化。结果手术后CSF纤维蛋白原增加(P<0.001),这与CSF/血浆白蛋白比值的增加有关(β=1.09,95% CI 0.47-1.71,P=0.004)。CSF 纤维蛋白原的峰值变化与 CSF 白细胞介素(IL)-10 和 IL-12p70 的变化相关。CSF纤维蛋白原的峰值变化与CSF总tau的变化相关(β=0.47,95% CI 0.24-0.71,P=0.002);但是,我们没有观察到纤维蛋白原与术后谵妄严重程度相关(发病率比=1.20,95% CI 0.66-2.17,P=0.540)。然而,在这个有限的队列中,我们并未观察到脑脊液纤维蛋白原与谵妄严重程度峰值之间存在关联。
{"title":"Association of preoperative to postoperative change in cerebrospinal fluid fibrinogen with postoperative delirium","authors":"Thomas Payne , Jennifer Taylor , David Kunkel , Katherine Konieczka , Frankie Ingram , Kaj Blennow , Henrik Zetterberg , Robert A. Pearce , Anke Meyer-Franke , Niccolò Terrando , Katerina Akassoglou , Robert D. Sanders , Richard C. Lennertz","doi":"10.1016/j.bjao.2024.100349","DOIUrl":"10.1016/j.bjao.2024.100349","url":null,"abstract":"<div><h3>Background</h3><div>We aimed to assess perioperative changes in fibrinogen in the cerebrospinal fluid (CSF), their association with markers of blood–brain barrier breakdown and neuroinflammation, and their association with postoperative delirium severity.</div></div><div><h3>Methods</h3><div>We conducted a secondary analysis of the Interventions for Postoperative Delirium-Biomarker 2 (IPOD-B2, NCT02926417) study, a prospective observational cohort study. We included 24 patients aged >21 yr undergoing aortic aneurysm repair. CSF samples were obtained before (<em>n</em>=24) and after surgery (<em>n</em>=13), with some participants having multiple postoperative samples. Our primary outcome was the perioperative change in CSF fibrinogen. Delirium was assessed using the Delirium Rating Scale-Revised-98.</div></div><div><h3>Results</h3><div>CSF fibrinogen increased after surgery (<em>P</em><0.001), and this was associated with an increase in CSF/plasma albumin ratio (β=1.09, 95% CI 0.47–1.71, <em>P</em>=0.004). The peak change in CSF fibrinogen was associated with the change in CSF interleukin (IL)-10 and IL-12p70. The peak change in CSF fibrinogen was associated with the change in CSF total tau (β=0.47, 95% CI 0.24–0.71, <em>P</em>=0.002); however, we did not observe an association with postoperative delirium severity (incidence rate ratio = 1.20, 95% CI 0.66–2.17, <em>P</em>=0.540).</div></div><div><h3>Conclusions</h3><div>Our preliminary findings support the hypothesis that fibrinogen enters the brain via blood-brain barrier disruption, promoting neuroinflammation and neuronal injury. However, we did not observe an association between cerebrospinal fluid fibrinogen and peak delirium severity in this limited cohort.</div></div>","PeriodicalId":72418,"journal":{"name":"BJA open","volume":"12 ","pages":"Article 100349"},"PeriodicalIF":0.0,"publicationDate":"2024-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142417277","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}